1. Oligodendroglial cell proliferation arising in an ovarian mature cystic teratoma. Clinicopathological, inmunohistochemical, and ultrastructural study of a case that may represent an oligodendroglioma.
- Author
-
Serrano-Arévalo ML, Lino-Silva LS, and Domínguez Malagón HR
- Subjects
- Female, Humans, Neoplasms, Cystic, Mucinous, and Serous chemistry, Neoplasms, Cystic, Mucinous, and Serous surgery, Neoplasms, Cystic, Mucinous, and Serous ultrastructure, Oligodendroglioma chemistry, Oligodendroglioma surgery, Oligodendroglioma ultrastructure, Ovarian Neoplasms chemistry, Ovarian Neoplasms surgery, Ovarian Neoplasms ultrastructure, Ovariectomy, Predictive Value of Tests, Salpingectomy, Teratoma chemistry, Teratoma surgery, Teratoma ultrastructure, Treatment Outcome, Young Adult, Biomarkers, Tumor analysis, Cell Proliferation, Immunohistochemistry, Microscopy, Electron, Neoplasms, Cystic, Mucinous, and Serous diagnosis, Oligodendroglioma diagnosis, Ovarian Neoplasms diagnosis, Teratoma diagnosis
- Abstract
Ovarian mature cystic teratoma (OMCT) is an ovarian benign neoplasm with excellent prognosis presenting components of the three germinal layers. However, transformation into a malignant neoplasm is a rare event (so-called somatic transformation). In most of the cases, the malignant component expresses as epidermoid carcinoma, but occasionally central nervous system tumors occur. Some of the previously reported tumors are astrocytoma, glioblastoma, and ependymoma. Somatic transformation of OMCT into an oligodendroglioma is exceptional. We report a 19-year-old female with a left OMCT with an area of oligonedroglial cells proliferation characterized by immunohistochemical studies with positivity for GFAP and S100, with a low Ki67 index (5%). Additionally, electron microscopy revealed oligodendrocytes with parallel bundles of cytoplasmic intermediate filaments, confirming the oligodendroglial nature of the proliferation. The patient was treated only with left oophorectomy, and three and half years after surgery, there is no evidence of disease.
- Published
- 2017
- Full Text
- View/download PDF